Answering questions on the Motley Fool Industry Focus podcast

| September 21, 2017

Tuned into Motley Fool’s Industry Focus podcast this week talking about how drugmakers get patents and drug trials through the FDA. The Q & A segment was  helpful for those looking to understand the process and pitfalls before adding shares of these companies to their portfolios.   Motley Fool Industry Focus Podcast (mp3) | 9/20/2017 […]

CVS Generic Competitor to EpiPen for $109.99

| January 12, 2017

CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers.The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of […]

A Walgreens buying Rite Aid deal could be $10 Billion

| October 28, 2015

With a few connections in the drug store world, it is always interesting to see who’s next in the acquisitions and mergers. On Tuesday, the financial news filled up mid-day with the latest deal: Walgreens Boots Alliance seeking to buy Rite Aid Corp. This would merge the second and third largest chains together and reduce […]

Promising additional drug treatment for Parkinson’s Disease

| February 26, 2013

While keeping an Internet-eye on research regarding medical conditions impacting friends and family, I came across a positive research article on an additional medication that is being looked at to treat Parkinson’s Disease. Northwestern University is planning another clinical test in hopes this new added drug treatment will slow the progression of the calcium build […]

Desultory - des-uhl-tawr-ee, -tohr-ee

  1. lacking in consistency, constancy, or visible order, disconnected; fitful: desultory conversation.
  2. digressing from or unconnected with the main subject; random: a desultory remark.